$70M Risperdal Verdict
July 25, 2016
On July 1, 2016, a Philadelphia jury returned its verdict in the amount of $70 million against Janssen Pharmaceuticals, Inc., which manufactures the antipsychotic medication Risperdal. The Philadelphia verdict is the largest verdict so far in the mass tort litigation involving Risperdal claims that [...]
Continue Reading
Arkansas Supreme Court Overturns $1.2B Risperdal Verdict
March 23, 2014
In its written opinion dated March 20, 2014, the Supreme Court of Arkansas (“Arkansas Supreme Court”) overturned a $1.2 billion verdict against Johnson & Johnson (“J & J”) arising out of the alleged improper marketing of its antipsychotic drug, Risperdal. The Arkans[...]
Continue Reading
